Current Status of Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma

Xinhao Chen, Runtian Xiao and Tao Zhang
Additional contact information
Xinhao Chen: Department of Oncology, Laboratory of Immunity, Inflammation & Cancer, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Runtian Xiao: Department of Oncology, Laboratory of Immunity, Inflammation & Cancer, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Tao Zhang: Department of Oncology, Laboratory of Immunity, Inflammation & Cancer, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

Journal of Innovations in Medical Research, 2025, vol. 4, issue 2, 59-65

Abstract: Nasopharyngeal carcinoma (NPC) has a unique endemic distribution in the world, with the highest incidence rate in South China, Southeast Asia and North Africa. About 70% of newly diagnosed nasopharyngeal carcinoma patients suffer from locally advanced diseases. The current methods of radiotherapy and chemotherapy include synchronous radiotherapy and chemotherapy, induction chemotherapy, and adjuvant chemotherapy. Induction chemotherapy has better tolerance, so higher drug concentrations can be used to improve the survival rate of locally advanced nasopharyngeal carcinoma patients. Induction chemotherapy can eliminate micro metastatic diseases early. This article provides a review of the application of induction chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma.

Keywords: locally advanced nasopharyngeal carcinoma; induction chemotherapy (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.paradigmpress.org/jimr/article/view/1603/1431 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bdz:joimer:v:4:y:2025:i:2:p:59-65

DOI: 10.63593/JIMR.2788-7022.2025.04.007

Access Statistics for this article

More articles in Journal of Innovations in Medical Research from Paradigm Academic Press
Bibliographic data for series maintained by Editorial Office ().